Mexico unveiled the world`s first approved dengue vaccine, saying the treatment is 60.5 percent effective against dengue and 93.2 percent effective against severe dengue.
The approval followed two years of clinical trials worldwide on more than 40,000 patients, including Mexicans, the health ministry said in a statement on Wednesday.
“This vaccine can prevent more than 8,000 hospitalisations, 104 deaths annually, and save 1.1 billion pesos ($64 million) each year in reduced costs tied to medical attention,” the statement said.
According to the World Health Organisation (WHO), “nearly 40 percent of the world`s population (3.9 billion people) is at risk of contracting dengue.”
Around 400 million people in more than 128 countries are infected with the mosquito-borne virus each year.
Sanofi said in a news release Wednesday that the vaccine, which it is calling Dengvaxia, was approved by Mexico’s Federal Commission for the Protection against Sanitary Risk for prevention of dengue in people 9 to 45 years old living in endemic areas.
“We are making dengue the next vaccine-preventable disease,” Olivier Charmeil, executive vice president for vaccines at Sanofi, said in an interview.